18 November 2024 in BMC Urology
Urinary tract infections (UTIs) are common however the widespread use of antibiotics has led to a rise in antimicrobial resistance (AMR) amongst uropathogens, rendering a significant proportion of infections resistant to first line treatment. AMR in UTIs may differentially affect men and women, younger and older patients. The purpose of this study was to investigate MDR (multi-drug resistance) and AMR in males and females in an Australian health district. There were 85,844 E. coli urinary isolates (2007–2020) analysed from adult patients. An E. coli isolate with MDR was defined as resistant to at least 1 agent in ≥ 3 antimicrobial classes. Chi-square tests and relative risk were calculated by comparing resistance in males and females and by age for antibiotics commonly used to treat UTIs in hospital and community collected samples. There was a higher proportion of MDR E. coli in males compared to females in both the community (6.4% vs. 5.2%, P < 0.001) and hospital datasets (16.5% vs. 12.8%, P < 0.001). The proportions of MDR for both males and females were significantly higher in the hospital setting. Resistance rates were higher in males compared to females for amoxicillin, amoxicillin/clavulanate, cephalexin and norfloxacin (p < 0.005), though not for trimethoprim. Antibiotic resistance was seen to increase over time. A higher proportion of MDR E. coli were noted in urine samples from males compared with females, possibly due to the increased likelihood of prior treatment for UTIs in men. Antimicrobial stewardship interventions could be targeted towards this cohort to address increasing rates of AMR.
29 October 2025 in Emergency Medicine Australasia
6 April 2026 in Journal of Global Antimicrobial Resistance
Antimicrobial resistance (AMR) is a universal health issue, causing significant morbidity and mortality. Enterobacter species is a gram-negative bacterial pathogen that has intrinsic and acquired resistance to multiple antibiotic classes. To determine trends in antibiotic resistance among Enterobacter isolates in community and hospital settings within the Illawarra Shoalhaven region of NSW, Australia. We analysed Enterobacter spp. isolates from a hospital-based (N = 2131) and a community-based (N = 1123) laboratory in Illawarra Shoalhaven, between 2007 and 2018. Trimethoprim, gentamicin, tobramycin, amikacin, ciprofloxacin, and meropenem resistance over the 11-y period was determined, and resistance trends and rates between community and hospital settings were compared, using statistical analysis (Pearson's chi-squared tests). AMR was significantly higher in hospital (14.9%) compared to community (8.9%) isolates. AMR reduced over the 11-y period for all antibiotics except amikacin and meropenem, for which resistance remained low throughout. Antibiotic resistance in Enterobacter spp. was higher in the hospital setting; however, resistance over time either significantly reduced (for most antibiotics) or remained stable (for some antibiotics) in both groups. The reduction was more pronounced in the hospital setting. This highlights the contribution of hospital-based infection-control measures, including the antimicrobial stewardship program.